On the public citation graph

The Physicochemical Challenges of Designing Multiple Ligands

0 signed · 201 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/s0169-409x(96)00423-1openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
inferredcites →https://doi.org/10.1016/s0960-894x(03)00018-0openalex-snapshot
Discovery of 4′-[(Imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/Angiotensin II receptor antagonists
inferredcites →https://doi.org/10.1016/s0960-894x(99)00320-0openalex-snapshot
Design and synthesis of a novel synthetic NAPAP-penta-saccharide conjugate displaying a dual antithrombotic action
inferredcites →https://doi.org/10.1016/s1359-6446(04)03163-0openalex-snapshot
From magic bullets to designed multiple ligands
inferredcites →https://doi.org/10.1021/ci010366aopenalex-snapshot
Is There a Difference between Leads and Drugs? A Historical Perspective
inferredcites →https://doi.org/10.1021/jm030267jopenalex-snapshot
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
inferredcites →https://doi.org/10.1021/jm049548xopenalex-snapshot
Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics
inferredcites →https://doi.org/10.1021/jm058225dopenalex-snapshot
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
inferredcites →https://doi.org/10.1021/jm950625lopenalex-snapshot
3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents
inferredcites →https://doi.org/10.1023/a:1015040217741openalex-snapshot
Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0471266949.bmc124openalex-snapshot
Medicinal Chemistry Approaches for Multitarget Drugs
inferred← citeshttps://doi.org/10.1002/9780470015902.a0028845openalex-snapshot
Multitarget Drug Discovery
inferred← citeshttps://doi.org/10.1002/9780470584170.ch5openalex-snapshot
Design of Multitarget Ligands
inferred← citeshttps://doi.org/10.1002/9781118098141.ch12openalex-snapshot
Selective Multitargeted Drugs
inferred← citeshttps://doi.org/10.1002/9781118098141.ch22openalex-snapshot
Multitargeted Drugs for Treatment of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/9781118943670.refsopenalex-snapshot
References
inferred← citeshttps://doi.org/10.1002/9781394182862.ch13openalex-snapshot
Multi‐target Drugs to Treat Metabolic Diseases
inferred← citeshttps://doi.org/10.1002/9781394182862.ch14openalex-snapshot
Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/9783527627448.ch13openalex-snapshot
Knowledge‐Based and Computational Approaches to In Vitro Safety Pharmacology
inferred← citeshttps://doi.org/10.1002/9783527674381.ch9openalex-snapshot
Merged Multiple Ligands
inferred← citeshttps://doi.org/10.1002/ardp.201800030openalex-snapshot
Synthesis of substituted fluorobenzimidazoles as inhibitors of 5‐lipoxygenase and soluble epoxide hydrolase for anti‐inflammatory activity
inferred← citeshttps://doi.org/10.1002/ardp.70335openalex-snapshot
Trends in Developing PPAR‐Gamma and FFAR1/GPCR40 Modulators for Managing Type‐II Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/cbdv.202200328openalex-snapshot
A Perspective Study on the RTK, PI3K, B‐Raf, CDK and the Multi‐Protein Targeting in Medicinal Chemistry
inferred← citeshttps://doi.org/10.1002/cmdc.201100126openalex-snapshot
Design and Synthesis of Novel Dual‐Action Compounds Targeting the Adenosine A2A Receptor and Adenosine Transporter for Neuroprotection
inferred← citeshttps://doi.org/10.1002/cmdc.201900607openalex-snapshot
Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity
inferred← citeshttps://doi.org/10.1002/cmdc.202000484openalex-snapshot
Turning Donepezil into a Multi‐Target‐Directed Ligand through a Merging Strategy
inferred← citeshttps://doi.org/10.1002/cmdc.202000858openalex-snapshot
Systematic Assessment of Fragment Identification for Multitarget Drug Design
inferred← citeshttps://doi.org/10.1002/ddr.21673openalex-snapshot
Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process
inferred← citeshttps://doi.org/10.1002/ddr.22125openalex-snapshot
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development
inferred← citeshttps://doi.org/10.1002/ejoc.201201303openalex-snapshot
Protoporphyrin IX/Cobyrinate Derived Hybrids – Novel Activators of Soluble Guanylyl Cyclase
inferred← citeshttps://doi.org/10.1002/med.20241openalex-snapshot
HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
inferred← citeshttps://doi.org/10.1002/minf.201100160openalex-snapshot
Application of GQSAR for Scaffold Hopping and Lead Optimization in Multitarget Inhibitors
inferred← citeshttps://doi.org/10.1002/minf.201300102openalex-snapshot
Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts
inferred← citeshttps://doi.org/10.1002/qsar.200860198openalex-snapshot
Identification of Novel Scaffolds from an Original Chemical Library as Potential Antipsychotics
inferred← citeshttps://doi.org/10.1002/slct.202002961openalex-snapshot
Progress in the Synthesis of Oxindole‐Naphthoquinone Molecular Hybrid Scaffolds: A Concise Review
inferred← citeshttps://doi.org/10.1007/16833_2024_491openalex-snapshot
Multitargeting Compounds in Cancer Research
inferred← citeshttps://doi.org/10.1007/7653_2018_17openalex-snapshot
Multitarget Drug Design for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-1-61779-520-6_15openalex-snapshot
A Medicinal Chemistry Perspective on Structure-Based Drug Design and Development
inferred← citeshttps://doi.org/10.1007/978-3-030-32857-3_3openalex-snapshot
The Efficiency of Multi-target Drugs: A Network Approach
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_12openalex-snapshot
Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
inferred← citeshttps://doi.org/10.1007/978-981-16-0999-2_3openalex-snapshot
Single Molecule Non-cleavable Multiply Active Antibacterials
inferred← citeshttps://doi.org/10.1007/s00044-014-0956-6openalex-snapshot
Synthesis and preliminary in vitro activity of mono- and bis-1H-1,2,3-triazole-tethered β-lactam–isatin conjugates against the human protozoal pathogen Trichomonas vaginalis
inferred← citeshttps://doi.org/10.1007/s00044-018-02287-0openalex-snapshot
Design, synthesis and biological evaluation of some novel diastereoselective β-lactams bearing 2-mercaptobenzothiazole and benzoquinoline
inferred← citeshttps://doi.org/10.1007/s10593-014-1496-1openalex-snapshot
Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource
inferred← citeshttps://doi.org/10.1007/s11011-015-9753-2openalex-snapshot
Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence
inferred← citeshttps://doi.org/10.1007/s11095-010-0065-2openalex-snapshot
In-Silico Approaches to Multi-target Drug Discovery
inferred← citeshttps://doi.org/10.1007/s40203-017-0028-yopenalex-snapshot
Xeronine structure and function: computational comparative mastery of its mystery
inferred← citeshttps://doi.org/10.1016/b978-0-08-101011-2.00004-0openalex-snapshot
Designed Hybrid Compounds for Tropical Parasitic Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-08-101011-2.00006-4openalex-snapshot
Multitarget Anti-Alzheimer Hybrid Compounds
inferred← citeshttps://doi.org/10.1016/b978-0-08-101011-2.00010-6openalex-snapshot
Medicinal Chemistry of Hybrids for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-08-102083-8.00001-7openalex-snapshot
Multitargeting Heterocycles
inferred← citeshttps://doi.org/10.1016/b978-0-12-374194-3.00018-4openalex-snapshot
Homo and Heterodimer Ligands: the Twin Drug Approach
inferred← citeshttps://doi.org/10.1016/b978-0-12-374194-3.00027-5openalex-snapshot
Multi-target Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12315-7openalex-snapshot
Multiobjective Optimization of Biological and Physical Properties in Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-417205-0.00019-5openalex-snapshot
Multitarget Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-323-90593-0.00015-0openalex-snapshot
Computational phytochemistry, databases, and tools
inferred← citeshttps://doi.org/10.1016/b978-0-443-29808-0.00014-5openalex-snapshot
Multiobjective optimization of biological and physical properties in drug discovery
inferred← citeshttps://doi.org/10.1016/j.bbr.2012.02.012openalex-snapshot
Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT4 receptor activation (RS67333) on object recognition in mice
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.02.019openalex-snapshot
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103073openalex-snapshot
The stilbene derivatives, nucleosides, and nucleosides modified by stilbene derivatives
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110078openalex-snapshot
Stereodivergent double Thia-Michael diversification of parthenin enables reduced cytotoxicity with retained anti-inflammatory activity
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.112842openalex-snapshot
Chemical profiles and pharmacological insights of Anisomeles indica Kuntze: An experimental chemico-biological interaction
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.02.007openalex-snapshot
Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: Introducing a diketoacid functionality into delavirdine
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.10.023openalex-snapshot
Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.09.023openalex-snapshot
Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.05.004openalex-snapshot
Pharmacophore and structure–activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase
inferred← citeshttps://doi.org/10.1016/j.bmc.2013.03.005openalex-snapshot
Design, synthesis and evaluation of tacrine–flurbiprofen–nitrate trihybrids as novel anti-Alzheimer’s disease agents
inferred← citeshttps://doi.org/10.1016/j.bmc.2023.117333openalex-snapshot
Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.bmc.2026.118754openalex-snapshot
Targeting the NAD+ salvage pathway: Identification of bifunctional NAMPT inhibitors and SIRT1 activators through pharmacophore-based virtual screening
inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.01.025openalex-snapshot
Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.11.047openalex-snapshot
Chloroquine–astemizole hybrids with potent in vitro and in vivo antiplasmodial activity
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.10.132openalex-snapshot
Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.05.092openalex-snapshot
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.12.109openalex-snapshot
1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: Synthesis and antimalarial evaluation
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.07.010openalex-snapshot
Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.08.063openalex-snapshot
Synthesis and evaluation of the NSCLC anti-cancer activity and physical properties of 4-aryl-N-phenylpyrimidin-2-amines
inferred← citeshttps://doi.org/10.1016/j.bmcl.2020.127514openalex-snapshot
Structural hybridization as a facile approach to new drug candidates
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108628openalex-snapshot
Discovery of biselyngbyaside B a novel lead inhibitor of drug-resistant bacteria targeting DNA gyrase B
inferred← citeshttps://doi.org/10.1016/j.drudis.2006.12.006openalex-snapshot
Fragments, network biology and designing multiple ligands
inferred← citeshttps://doi.org/10.1016/j.drudis.2010.12.002openalex-snapshot
Lead optimization in the nondrug-like space
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.02.006openalex-snapshot
Designed multiple ligands in metabolic disease research: from concept to platform
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.08.019openalex-snapshot
Reconsidering the drug discovery pipeline for designed multitarget drugs
inferred← citeshttps://doi.org/10.1016/j.drudis.2015.12.007openalex-snapshot
In silico methods to address polypharmacology: current status, applications and future perspectives
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.11.013openalex-snapshot
Analysis of solvent-exposed and buried co-crystallized ligands: a case study to support the design of novel protein–protein interaction inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.11.025openalex-snapshot
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.03.023openalex-snapshot
Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.06.036openalex-snapshot
Three-component synthesis of chromeno β-lactam hybrids for inflammation and cancer screening
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113397openalex-snapshot
Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114655openalex-snapshot
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119186openalex-snapshot
Epigenetic strategies for fetal hemoglobin induction in sickle cell disease
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2015.03.012openalex-snapshot
Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2007.02.003openalex-snapshot
Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone
inferred← citeshttps://doi.org/10.1016/j.nurt.2008.10.039openalex-snapshot
Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs
inferred← citeshttps://doi.org/10.1016/j.pharmr.2025.100038openalex-snapshot
Polypharmacological strategies for infectious bacteria
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2017.05.005openalex-snapshot
Cytochrome P450-derived eicosanoids and heart function
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.106055openalex-snapshot
Polypharmacology: The science of multi-targeting molecules
inferred← citeshttps://doi.org/10.1016/s0065-7743(10)45024-1openalex-snapshot
Reducing the Risk of Drug Attrition Associated with Physicochemical Properties
inferred← citeshttps://doi.org/10.1017/s1461145712001496openalex-snapshot
On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal
inferred← citeshttps://doi.org/10.1021/acs.chemrev.8b00728openalex-snapshot
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00914openalex-snapshot
Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00931openalex-snapshot
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01357openalex-snapshot
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00100openalex-snapshot
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00417openalex-snapshot
Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01585openalex-snapshot
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c02150openalex-snapshot
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00589openalex-snapshot
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01192openalex-snapshot
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as “Antidiabesity” Agents Based on Repurposing and Morphing of WB-4101
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00115openalex-snapshot
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00386openalex-snapshot
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01287openalex-snapshot
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00760openalex-snapshot
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00017openalex-snapshot
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01256openalex-snapshot
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00102openalex-snapshot
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.9b00039openalex-snapshot
Harnessing Polypharmacology with Medicinal Chemistry
inferred← citeshttps://doi.org/10.1021/bc200645nopenalex-snapshot
Design, Synthesis, and Initial Biological Evaluation of a Steroidal Anti-Estrogen–Doxorubicin Bioconjugate for Targeting Estrogen Receptor-Positive Breast Cancer Cells
inferred← citeshttps://doi.org/10.1021/jm070512popenalex-snapshot
Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase
inferred← citeshttps://doi.org/10.1021/jm100293fopenalex-snapshot
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
inferred← citeshttps://doi.org/10.1021/jm2001376openalex-snapshot
Synthesis and Structure−Activity Relationship Studies of Urea-Containing Pyrazoles as Dual Inhibitors of Cyclooxygenase-2 and Soluble Epoxide Hydrolase
inferred← citeshttps://doi.org/10.1021/jm3009844openalex-snapshot
Enhanced Anti-influenza Agents Conjugated with Anti-inflammatory Activity
inferred← citeshttps://doi.org/10.1021/jm400715hopenalex-snapshot
Synthesis and Evaluation of Bifunctional sGC Regulators: Optimization of a Connecting Linker
inferred← citeshttps://doi.org/10.1021/jm7009364openalex-snapshot
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1021/jm701225uopenalex-snapshot
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/jm8003448openalex-snapshot
3,4-Dihydro-2H-1,4-benzoxazine Derivatives Combining Thrombin Inhibitory and Glycoprotein IIb/IIIa Receptor Antagonistic Activity as a Novel Class of Antithrombotic Compounds with Dual Function
inferred← citeshttps://doi.org/10.1021/jm901132vopenalex-snapshot
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
inferred← citeshttps://doi.org/10.1021/jm901272dopenalex-snapshot
Design, Synthesis, and Docking Studies of Novel Benzimidazoles for the Treatment of Metabolic Syndrome
inferred← citeshttps://doi.org/10.1021/jm901614bopenalex-snapshot
Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1Receptor Antagonism
inferred← citeshttps://doi.org/10.1021/ml1002162openalex-snapshot
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase
inferred← citeshttps://doi.org/10.1021/ml200091qopenalex-snapshot
Discovery of Potent Dual PPARα Agonists/CB1 Ligands
inferred← citeshttps://doi.org/10.1021/ml200268wopenalex-snapshot
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity
inferred← citeshttps://doi.org/10.1038/nchembio.118openalex-snapshot
Network pharmacology: the next paradigm in drug discovery
inferred← citeshttps://doi.org/10.1038/npp.2013.148openalex-snapshot
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
inferred← citeshttps://doi.org/10.1038/nrd2445openalex-snapshot
The influence of drug-like concepts on decision-making in medicinal chemistry
inferred← citeshttps://doi.org/10.1038/srep46277openalex-snapshot
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
inferred← citeshttps://doi.org/10.1039/9781849734912-00130openalex-snapshot
In Silico Lead Generation Approaches in Multi-Target Drug Discovery
inferred← citeshttps://doi.org/10.1039/9781849734912-00141openalex-snapshot
The Challenges of Multi-Target Lead Optimization
inferred← citeshttps://doi.org/10.1039/9781849734912-00290openalex-snapshot
Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design
inferred← citeshttps://doi.org/10.1039/9781849734943-00510openalex-snapshot
Multi-target Drug Discovery for Psychiatric Disorders
inferred← citeshttps://doi.org/10.1039/b901356copenalex-snapshot
Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity
inferred← citeshttps://doi.org/10.1039/b908147jopenalex-snapshot
Structure and organization of drug-target networks: insights from genomic approaches for drug discovery
inferred← citeshttps://doi.org/10.1039/c2ob25902hopenalex-snapshot
Convergent synthesis of a steroidal antiestrogen-mitomycin C hybrid using “click” chemistry
inferred← citeshttps://doi.org/10.1073/pnas.1410315111openalex-snapshot
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
inferred← citeshttps://doi.org/10.1080/17460441.2017.1280024openalex-snapshot
Computational polypharmacology: a new paradigm for drug discovery
inferred← citeshttps://doi.org/10.1093/bioadv/vbab031openalex-snapshot
pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures
inferred← citeshttps://doi.org/10.1096/fj.15-270637openalex-snapshot
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage
inferred← citeshttps://doi.org/10.1177/1087057113506118openalex-snapshot
Neoclassic Drug Discovery: The Case for Lead Generation Using Phenotypic and Functional Approaches
inferred← citeshttps://doi.org/10.1186/1472-6750-9-57openalex-snapshot
Interfering ribonucleic acids that suppress expression of multiple unrelated genes
inferred← citeshttps://doi.org/10.1186/s40169-017-0181-2openalex-snapshot
A perspective on multi‐target drug discovery and design for complex diseases
inferred← citeshttps://doi.org/10.1201/b19081-22openalex-snapshot
Marine Natural Products in Pharma: How Industry Missed the Boat
inferred← citeshttps://doi.org/10.1211/jpp.60.2.0007openalex-snapshot
Evaluation of the NO-releasing properties of NO-donor linkers
inferred← citeshttps://doi.org/10.1351/pac200880081693openalex-snapshot
Multitarget drugs: Focus on the NO-donor hybrid drugs
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1006619openalex-snapshot
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
inferred← citeshttps://doi.org/10.1517/13543770802630331openalex-snapshot
Muscarinic antagonist-β-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review
inferred← citeshttps://doi.org/10.1517/17425250903042318openalex-snapshot
Physicochemical drug properties associated within vivotoxicological outcomes: a review
inferred← citeshttps://doi.org/10.1517/17460440802564845openalex-snapshot
An update on hybrid drugs in cardiovascular drug research
inferred← citeshttps://doi.org/10.1517/17460440903584874openalex-snapshot
When analoging is not enough: scaffold discovery in medicinal chemistry
inferred← citeshttps://doi.org/10.1517/17460441.2.5.603openalex-snapshot
The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS
inferred← citeshttps://doi.org/10.1517/17460441.2013.743991openalex-snapshot
Multitarget ligands in antibacterial research: progress and opportunities
inferred← citeshttps://doi.org/10.1517/17460441.2013.744746openalex-snapshot
Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders
inferred← citeshttps://doi.org/10.1530/jme-18-0045openalex-snapshot
SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
inferred← citeshttps://doi.org/10.17863/cam.38293openalex-snapshot
Computer-Aided Design of Ligands at Multiple Protein Targets for Multifactorial Diseases
inferred← citeshttps://doi.org/10.2174/0929867311320130002openalex-snapshot
Human Disease and Drug Pharmacology, Complex as Real Life
inferred← citeshttps://doi.org/10.2174/138161209788453266openalex-snapshot
Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
inferred← citeshttps://doi.org/10.2174/156802612801319016openalex-snapshot
Identifying Multiple-target Ligands via Computational Chemogenomics Approaches
inferred← citeshttps://doi.org/10.2174/1568026611313090006openalex-snapshot
Methods and Applications of Structure Based Pharmacophores in Drug Discovery
inferred← citeshttps://doi.org/10.2174/1568026619666190619115735openalex-snapshot
Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
inferred← citeshttps://doi.org/10.2174/1568026620666200819151342openalex-snapshot
Hybridization Approach to Drug Discovery Inhibiting Mycobacterium tuberculosis-An Overview
inferred← citeshttps://doi.org/10.2174/1568026621666211111153626openalex-snapshot
The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil
inferred← citeshttps://doi.org/10.2174/1570159x14666160119094820openalex-snapshot
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease
inferred← citeshttps://doi.org/10.2174/1570159x16666180315141643openalex-snapshot
Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
inferred← citeshttps://doi.org/10.2174/1573406415666190416120801openalex-snapshot
Recent Advances in Therapeutic Applications of Bisbenzimidazoles
inferred← citeshttps://doi.org/10.32352/0367-3057.4.19.07openalex-snapshot
In silico screening of drug-like molecules for the treatment of cardiovascular diseases on the basis of five-membered privileged heterocycles
inferred← citeshttps://doi.org/10.3389/fchem.2020.00142openalex-snapshot
LigBuilder V3: A Multi-Target de novo Drug Design Approach
inferred← citeshttps://doi.org/10.3389/fmicb.2016.00174openalex-snapshot
Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
inferred← citeshttps://doi.org/10.3389/fphar.2020.554961openalex-snapshot
Multi-Target Approaches in Metabolic Syndrome
inferred← citeshttps://doi.org/10.3389/fphar.2024.1419110openalex-snapshot
Medicinal polypharmacology—a scientific glossary of terminology and concepts
inferred← citeshttps://doi.org/10.3390/biomedicines9040366openalex-snapshot
Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
inferred← citeshttps://doi.org/10.3390/computation7020026openalex-snapshot
Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models
inferred← citeshttps://doi.org/10.3390/genes14112048openalex-snapshot
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
inferred← citeshttps://doi.org/10.3390/molecules21040466openalex-snapshot
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/molecules22010045openalex-snapshot
Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase
inferred← citeshttps://doi.org/10.3390/molecules23030634openalex-snapshot
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
inferred← citeshttps://doi.org/10.3390/molecules25081821openalex-snapshot
Binding-Site Match Maker (BSMM): A Computational Method for the Design of Multi-Target Ligands
inferred← citeshttps://doi.org/10.3390/molecules25153337openalex-snapshot
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
inferred← citeshttps://doi.org/10.3390/molecules26102852openalex-snapshot
Steroid Sulphatase and Its Inhibitors: Past, Present, and Future
inferred← citeshttps://doi.org/10.3390/ph14111164openalex-snapshot
The Fellowship of Privileged Scaffolds—One Structure to Inhibit Them All
inferred← citeshttps://doi.org/10.3390/ph15050545openalex-snapshot
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
inferred← citeshttps://doi.org/10.3390/ph15091092openalex-snapshot
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications
inferred← citeshttps://doi.org/10.3390/ph15121560openalex-snapshot
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/pharmaceutics16080982openalex-snapshot
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
inferred← citeshttps://doi.org/10.3724/bnsfc-2025.06.04.0001openalex-snapshot
From Rational Design to Clinical Translation:Current Status and Future Perspectives of Multi-target Small-molecule Drugs
inferred← citeshttps://doi.org/10.4155/fmc.09.87openalex-snapshot
Novel Heterodimer Antibiotics: A Review of Recent Patent Literature
inferred← citeshttps://doi.org/10.4155/fmc.14.56openalex-snapshot
Multitarget Ligands and Theranostics: Sharpening the Medicinal Chemistry Sword Against Prion Diseases
inferred← citeshttps://doi.org/10.4155/fmc.14.7openalex-snapshot
Potential Strategies for Increasing Drug-Discovery Productivity
inferred← citeshttps://doi.org/10.5772/33169openalex-snapshot
New Antitubercular Drugs Designed by Molecular Modification
inferred← citeshttps://doi.org/10.5812/jrps-154599openalex-snapshot
The Production of TNF-α and Nitric Oxide in Rat Alveolar Macrophages Is Blunted by Isatin-Glycine Hybrids
inferred← citeshttps://doi.org/10.5935/1984-6835.20150074openalex-snapshot
The Efavirenz: Structure-Activity Relantionship and Synthesis Methods
inferred← citeshttps://doi.org/10.70675/2c55b4d4z9527z419az9e02z8d47d85e9cf3openalex-snapshot
Conception, synthèse et évaluation de nouveaux composés à dualité d'action agoniste des récepteurs 5-HT4 et antioxydante, d'intérêt thérapeutique pléiotrope dans la maladie d'Alzheimer
inferred← citeshttps://doi.org/10.7759/cureus.89028openalex-snapshot
Evaluation of Effectiveness and Tolerability of Saroglitazar in Metabolic Disease Patients of India: A Retrospective, Observational, Electronic Medical Record-Based Real-World Evidence Study
inferred← citeshttps://doi.org/10.7939/r3-ha5a-nh95openalex-snapshot
Cardioprotective Effects of Soluble Epoxide Hydrolase Inhibition Following Myocardial Infarction
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.